: Contaminated eye drops from Walmart, CVS and Target linked to factory in India where workers reportedly went barefoot and faked safety checks

Daily Trade

The tainted eye drops that the Food and Drug Administration recently warned people to stop using ASAP have reportedly been traced back to a factory in India. 

The more than two dozen affected eye-drop brands sold by retailers like Walmart, CVS, Target and Rite Aid were made by Kilitch Healthcare India Ltd. in Navi Mumbai, India, according to a federal inspection report seen by Bloomberg News

The report cites unsanitary conditions in the factory, such as workers being barefoot in the facility and falsifying test results so that the products made there appeared to be safe, according to the news site. The FDA has banned the Kilitch factory from shipping any more of its eye drops to the U.S. The FDA also asked the factory to recall its eye drops, but it has not done so yet. 

Representatives from Kilitch were not immediately available for comment.

Last month, the FDA warned that more than two dozen over-the-counter eye drops sold by retailers including Walmart
WMT,
+0.63%
,
CVS
CVS,
-0.64%
,
Target
TGT,
-1.06%

and Rite Aid
RADCQ,
+9.73%

posed a risk of eye infections that could cause partial vision loss or blindness. It advised shoppers to stop buying these products, which were also sold under the Velocity Pharma brand and Cardinal Health Inc.’s
CAH,
+1.08%

 Rugby and Leader labels, and to quit using them immediately. Many of these retailers and pharmacies also pulled the products from their shelves. 

Read more: CVS, Target and other eye-drop products pose risk of dangerous infections, FDA warns

If you’re concerned about whether you have any of these infected products in your home, check out the complete list from the FDA

See also: FDA’s eye-drops recall: The full list of CVS, Walmart, Target and Rite Aid products that you should stop using ASAP

This news comes several months after U.S. health authorities also linked eye drops made by a different company in India to eye infections that were ultimately blamed for four deaths and 18 cases of vision loss in the United States. 

Articles You May Like

S&P 500, Nasdaq-100 are getting an update. Trillions depend on who’s in and who’s out
Here’s why FedEx plans to spin off its freight business
Are These AI Stocks Ready for a Comeback?
Starboard sees an opportunity to create value at Riot Platforms amid growth in hyperscalers
Nike just laid out an ambitious turnaround plan. But it will come at a cost.